These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
88 related articles for article (PubMed ID: 10907083)
61. Germline MLH1 and MSH2 mutational spectrum including frequent large genomic aberrations in Hungarian hereditary non-polyposis colorectal cancer families: implications for genetic testing. Papp J; Kovacs ME; Olah E World J Gastroenterol; 2007 May; 13(19):2727-32. PubMed ID: 17569143 [TBL] [Abstract][Full Text] [Related]
62. RET proto-oncogene genotyping using unlabeled probes, the masking technique, and amplicon high-resolution melting analysis. Margraf RL; Mao R; Highsmith WE; Holtegaard LM; Wittwer CT J Mol Diagn; 2007 Apr; 9(2):184-96. PubMed ID: 17384210 [TBL] [Abstract][Full Text] [Related]
63. [Adequate system for investigation of translation initiation of the human retrotransposon L1 mRNA in vitro]. Dmitriev SE; Bykova NV; Andreev DE; Terenin IM Mol Biol (Mosk); 2006; 40(1):25-30. PubMed ID: 16523688 [TBL] [Abstract][Full Text] [Related]
64. Combined SSCP/duplex analysis by capillary electrophoresis for more efficient mutation detection. Kozlowski P; Krzyzosiak WJ Nucleic Acids Res; 2001 Jul; 29(14):E71. PubMed ID: 11452040 [TBL] [Abstract][Full Text] [Related]
65. Direct genomic multiplex PCR for BRCA1 and application to mutation detection by single-strand conformation and heteroduplex analysis. Barker DF Hum Mutat; 2000 Oct; 16(4):334-44. PubMed ID: 11013444 [TBL] [Abstract][Full Text] [Related]
66. High proportion of missense mutations of the BRCA1 and BRCA2 genes in Japanese breast cancer families. Katagiri T; Kasumi F; Yoshimoto M; Nomizu T; Asaishi K; Abe R; Tsuchiya A; Sugano M; Takai S; Yoneda M; Fukutomi T; Nanba K; Makita M; Okazaki H; Hirata K; Okazaki M; Furutsuma Y; Morishita Y; Iino Y; Karino T; Ayabe H; Hara S; Kajiwara T; Houga S; Miki Y J Hum Genet; 1998; 43(1):42-8. PubMed ID: 9609997 [TBL] [Abstract][Full Text] [Related]
67. Detection of congenital color vision defects using heteroduplex-SSCP analysis. Zhang Q; Minoda K Jpn J Ophthalmol; 1996; 40(1):79-85. PubMed ID: 8739504 [TBL] [Abstract][Full Text] [Related]
68. Sequence alterations can mask each other's presence during screening with SSCP or heteroduplex analysis: BRCA genes as examples. Orban TI; Csokay B; Olah E Biotechniques; 2000 Jul; 29(1):94-8. PubMed ID: 10907083 [TBL] [Abstract][Full Text] [Related]
69. Single-strand conformation polymorphism and heteroduplex analysis for gel-based mutation detection. Nataraj AJ; Olivos-Glander I; Kusukawa N; Highsmith WE Electrophoresis; 1999 Jun; 20(6):1177-85. PubMed ID: 10380757 [TBL] [Abstract][Full Text] [Related]
70. [Genetic alterations and DNA-based diagnosis in breast cancer]. Matsumoto S; Emi M; Kasumi F; Nakamura Y Nihon Geka Gakkai Zasshi; 1996 May; 97(5):375-80. PubMed ID: 8709940 [TBL] [Abstract][Full Text] [Related]
71. Pitfalls and caveats in BRCA sequencing. Bellosillo B; Tusquets I Ultrastruct Pathol; 2006; 30(3):229-35. PubMed ID: 16825125 [TBL] [Abstract][Full Text] [Related]
72. Detection of mutations and polymorphisms in the p53 tumor suppressor gene by single-strand conformation polymorphism analysis. Kutach LS; Bolshakov S; Ananthaswamy HN Electrophoresis; 1999 Jun; 20(6):1204-10. PubMed ID: 10380760 [TBL] [Abstract][Full Text] [Related]